A sudden contamination scare has forced A2 Milk to pull back thousands of US-bound infant formula cans, rattling investors and parents alike. Market reaction is swift and brutal, with the stock dropping more than 11% as traders question how much damage this episode could do to the brand’s ambitions in the US and in China.
Anxiety is sharpened by memories of earlier formula scandals that reshaped the global market and left consumers hypersensitive to safety risks.
A2 Milk, headquartered in Auckland, only entered the US infant formula market under emergency conditions during the pandemic, when regulators granted temporary access after Abbott Laboratories shut a key plant linked to serious bacterial contamination. Abbott’s crisis followed illnesses in four infants and two deaths, eventually resulting in a $US495 million ($687 million) compensation bill in 2024.
A2 Milk has been trying to build a foothold under those special import rights, which expired on 31 December, and the recalled product relates to its USA-label formula made under that temporary programme. The formula was manufactured by Synlait Milk and sold through A2 Milk’s own website, Amazon and Meijer stores, before being discontinued even prior to the formal recall.
Tests on ingredients used in the USA-label formula detected cereulide, a powerful cyclic peptide toxin capable of causing severe vomiting and illness in children, prompting A2 Milk to recall three affected batches in the US. Trading screens showed investors reacting sharply, with the share price down 11.35% to $6.44 at 12:31pm AEST, even though the company reported no confirmed cases of infant harm so far.
A2 Milk is working with the US Food and Drug Administration and has issued guidance for American consumers on what to do if they hold the recalled product. Management has also stressed that A2 Platinum products sold outside the US are not impacted and says it does not expect a hit to financial earnings from the recall at this stage.
Investors remain worried less about the direct cost of the recall and more about longer-term trust in A2 Milk’s brand, especially in China, which is a far more profitable market than the US. Parents in Asia and North America already scrutinise formula safety closely after years of contamination scares and high-profile recalls.
A2 Milk is trying to draw a clear line between the discontinued USA-label product and its core international portfolio, but the share price reaction suggests markets are bracing for potential reputational fallout beyond the immediate recall.
